Pfizer joins forces with SCI as it expands cross-industry network

22 June 2023


Receive more stories like this from SCI via email


Pharmaceutical company becomes the latest SCI corporate partner.

Leading global innovation hub SCI is pleased to announce a partnership agreement with Pfizer UK. The Surrey-headquartered company is a major supplier of medicines to the NHS. It has had a 70-year presence in the UK, working across healthcare organisations to deliver on its purpose of breakthroughs that change patients’ lives in the UK and around the world.

Pfizer has a longstanding commitment to UK science, with over £1.5 billion invested in UK R&D since 2016. During 2022, it forged over a hundred R&D collaborations with universities, pharmaceutical companies, industries, and others across the UK.

Partnering with SCI will enable Pfizer to further expand existing networks to boost innovation as it recognises that collaboration is crucial to unlocking medical breakthroughs including better understanding disease and developing targeted treatments.

Gemma Scotney, Director, UK Process Chemistry at Pfizer said:

‘Pfizer is proud to have the opportunity to be part of the SCI corporate partnership, a close network of over 15 cross-industry organisations. The partnership has great diversity in terms of size and industry, and we feel it will give us the opportunity to collaborate on early-stage R&D approaches, understand common challenges, innovate together and collectively drive forward and direct key areas of focus across the technical and specialist interest groups.’

The agreement will assist Pfizer in further driving innovation through collaboration via access to SCI’s leading-edge training and development programmes, international networks, digital platforms, conferences and portfolio of publications including SCI’s well established C&I magazine.

SCI also runs cutting edge conferences and events and has recently launched new industry focused awards recognising excellence in Sustainability and Innovation through Partnership.

If you would like to discuss becoming an SCI corporate partner or joining any of SCI’s other Partnership schemes which include SME Partnership, Academic Partnership and Associate Membership please contact our membership team to arrange an introductory meeting.


Notes to editors:

About SCI: where science meets business

SCI is a unique global multidisciplinary innovation network bringing together scientists, inventors and entrepreneurs to develop scientific solutions to the biggest challenges facing society today. 

SCI works across crucial sectors as diverse as food and agriculture, renewable energy, sustainability and health and wellbeing.

For more information, please visit

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS.

To learn more about our commitments, please visit us at or follow us on Twitter (@Pfizer_UK), Facebook (@PfizerUK) and Instagram (@pfizeruk). 


SCI's Digital Media team

Contact the SCI Digital Media team